Literature DB >> 32474959

Mental health status of dermatologists during the COVID-19 pandemic: A technology-based therapy.

Mohamad Goldust1,2, Komal Agarwal3, George Kroumpouzos4,5, Mohammad Jafferany6, Torello Lotti7, Indrashis Podder8.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32474959      PMCID: PMC7300558          DOI: 10.1111/dth.13723

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   3.858


× No keyword cloud information.
Dear Editor, The high infectivity and communicability of the new corona virus disease (COVID‐19), even during incubation period, coupled with substantial mortality due to unavailability of specific treatment, has resulted in immense psychological stress among health care workers (HCWs). , , , Although frontline HCWs in fever clinics, isolation wards, and intensive care units share the maximum brunt, no speciality is immune to it's psychological sequelae like fear, stress, anxiety, and depression. Dermatologists can be exposed to COVID‐19 during their postings in emergency rooms and intensive care units to tide over the shortage of emergency/intensive care specialists, apart from treating many outdoor patients. Dermatologists may be exposed to the virus under following scenarios : Triage and infection screening for outpatients with skin disease: The role of a dermatologist becomes important when a febrile patient with cough/respiratory distress presents with skin rash. Such a fever may have been caused by COVID‐19, thus increasing their risk of exposure. Management of in‐patients suspected to harbor COVID‐19: Asymptomatic patients may be admitted to Dermatology wards. Additionally, dermatologists may be deputed at critical care units in such an extraordinary situation. Besides, the global shortage of personal protective equipment (PPE) adds to the anxiety of HCWs including dermatologists. Nosocomial infections have also increased during this time. Management of confirmed COVID‐19 patients with skin disease: This scenario puts dermatologists at direct risk of exposure to COVID‐19. Although it is recommended that treating physicians send images of skin lesions to dermatologists via email and teledermatology, it is often impossible to diagnose the skin lesions without direct visual examination. Thus, dermatologists have a considerable risk of exposure to COVID‐19, especially in hospital set‐ups; thus harboring substantial fear of infection and/or death. Several frontline HCWs have died in China, and 20 of 44 recent deaths in Philadelphia were HCWs. HCWs positive for COVID‐19 test are being quarantined, which magnifies the fears. Furthermore, previous pandemics have shown that quarantined HCWs may experience post‐traumatic stress disorder (PTSD). Fear of cross‐infecting their contacts has driven them away from homes; this social confinement with additional workload and lack of PPE has worsened their mental health, resulting in acute stress, depression, and substance abuse. HCWs may feel betrayed by the system or their employers as they are being forced to work beyond their speciality, for long hours without any additional incentive, to overcome the shortage of trained manpower. The ensuing dilemma between professional commitments and protecting themselves or their family worsens the mental crisis, which may last for years manifesting as PTSD, subsequently manifesting as avoidance behavior, minimizing patient contact over years, while some may be deemed mentally unfit to join regular duties. A study from China reported it's prevalence to be 7%, predominantly affecting females with poor sleep quality. Additionally, dealing with uncooperative patients are increasing the stress of all HCWs, occasionally manifesting as irritability, excitability, and unwillingness to rest. Even the dermatologists engaged solely private practice, are not immune to this mental turmoil. Eventually every pandemic ushers in an economic downfall. Home‐quarantine results in economic loss promoting anxiety. The fear of uncertainty, death and all the above factor deteriorates the mental health of doctors, which may even lead to increased suicides. This pandemic has generated mental health problems among doctors irrespective of their speciality. A multicenter survey involving 1563 Chinese medical staff, revealed depression in 50.7%, anxiety in 44.7%, while 36.1% and 73.4% developed insomnia other stress‐related symptoms, respectively. This survey highlights the overlooked mental health status of doctors. However, we are fortunate to have technology like smartphones and internet, at our disposal; various online sites can be used to provide mental support in the form of psychological counseling or self‐help interventions including cognitive behavioral therapy. We may not have solution to all problems, but it is important to address what we can presently, thus enabling health authorities allocate resources to ensure the mental well‐being of the healers. In conclusion, COVID‐19 has resulted in severe mental distress of dermatologists, manifesting as fear, panic, anxiety, depression, insomnia, PTSD, and even suicide. As dermatology is not traditionally viewed as an “emergency” specialty, the mental health concern for dermatologists remains unaddressed. The authors recommend timely appropriate measures to address such concerns in dermatologists, at par with other HCWs.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.
  9 in total

1.  Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department.

Authors:  J Tao; Z Song; L Yang; C Huang; A Feng; X Man
Journal:  Br J Dermatol       Date:  2020-04-20       Impact factor: 9.302

2.  COVID-19 and SARS: Differences and similarities.

Authors:  Antonio Caldaria; Claudio Conforti; Nicola Di Meo; Caterina Dianzani; Mohammad Jafferany; Torello Lotti; Iris Zalaudek; Roberta Giuffrida
Journal:  Dermatol Ther       Date:  2020-04-30       Impact factor: 2.851

3.  Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed.

Authors:  Yu-Tao Xiang; Yuan Yang; Wen Li; Ling Zhang; Qinge Zhang; Teris Cheung; Chee H Ng
Journal:  Lancet Psychiatry       Date:  2020-02-04       Impact factor: 27.083

4.  The effect of quarantine and isolation for COVID-19 in general population and dermatologic treatments.

Authors:  Aseem Sharma; Regina Fölster-Holst; Martin Kassir; Jacek Szepietowski; Mohammad Jafferany; Torello Lotti; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-25       Impact factor: 2.851

5.  Priorities for global health community in COVID-19 pandemic.

Authors:  Lidia Rudnicka; Mrinal Gupta; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-08       Impact factor: 2.851

6.  Solidarity and transparency against the COVID-19 pandemic.

Authors:  Gulhima Arora; George Kroumpouzos; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Zuzanna Sitkowska; Stephan Grabbe; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-13       Impact factor: 2.851

7.  Online mental health services in China during the COVID-19 outbreak.

Authors:  Shuai Liu; Lulu Yang; Chenxi Zhang; Yu-Tao Xiang; Zhongchun Liu; Shaohua Hu; Bin Zhang
Journal:  Lancet Psychiatry       Date:  2020-02-19       Impact factor: 27.083

8.  Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter.

Authors:  Nianqi Liu; Fan Zhang; Cun Wei; Yanpu Jia; Zhilei Shang; Luna Sun; Lili Wu; Zhuoer Sun; Yaoguang Zhou; Yan Wang; Weizhi Liu
Journal:  Psychiatry Res       Date:  2020-03-16       Impact factor: 3.222

9.  COVID-19 and economy.

Authors:  Mrinal Gupta; Ayman Abdelmaksoud; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-08       Impact factor: 3.858

  9 in total
  2 in total

1.  Artificial intelligence in diagnosis and management of COVID-19 in dermatology.

Authors:  Roxanna Sadoughifar; Mohamad Goldust; Hormoz Abdshahzadeh; Reyhaneh Abrishamchi; Lidia Rudnicka; Mohammad Jafferany; Mrinal Gupta
Journal:  Dermatol Ther       Date:  2020-07-03       Impact factor: 3.858

2.  Mental distress in dermatologists during COVID-19 pandemic: Assessment and risk factors in a global, cross-sectional study.

Authors:  Shashank Bhargava; Rashmi Sarkar; George Kroumpouzos
Journal:  Dermatol Ther       Date:  2020-09-03       Impact factor: 3.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.